Skip to Content
Merck
  • X-ray structures of GluCl in apo states reveal a gating mechanism of Cys-loop receptors.

X-ray structures of GluCl in apo states reveal a gating mechanism of Cys-loop receptors.

Nature (2014-08-22)
Thorsten Althoff, Ryan E Hibbs, Surajit Banerjee, Eric Gouaux
ABSTRACT

Cys-loop receptors are neurotransmitter-gated ion channels that are essential mediators of fast chemical neurotransmission and are associated with a large number of neurological diseases and disorders, as well as parasitic infections. Members of this ion channel superfamily mediate excitatory or inhibitory neurotransmission depending on their ligand and ion selectivity. Structural information for Cys-loop receptors comes from several sources including electron microscopic studies of the nicotinic acetylcholine receptor, high-resolution X-ray structures of extracellular domains and X-ray structures of bacterial orthologues. In 2011 our group published structures of the Caenorhabditis elegans glutamate-gated chloride channel (GluCl) in complex with the allosteric partial agonist ivermectin, which provided insights into the structure of a possibly open state of a eukaryotic Cys-loop receptor, the basis for anion selectivity and channel block, and the mechanism by which ivermectin and related molecules stabilize the open state and potentiate neurotransmitter binding. However, there remain unanswered questions about the mechanism of channel opening and closing, the location and nature of the shut ion channel gate, the transitions between the closed/resting, open/activated and closed/desensitized states, and the mechanism by which conformational changes are coupled between the extracellular, orthosteric agonist binding domain and the transmembrane, ion channel domain. Here we present two conformationally distinct structures of C. elegans GluCl in the absence of ivermectin. Structural comparisons reveal a quaternary activation mechanism arising from rigid-body movements between the extracellular and transmembrane domains and a mechanism for modulation of the receptor by phospholipids.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
2-Oleoyl-1-palmitoyl-sn-glycero-3-phosphocholine, ≥95.5% (GC), ≥98% (TLC)
Sigma-Aldrich
2-Oleoyl-1-palmitoyl-sn-glycero-3-phosphocholine, ≥99.0% (TLC)
Sigma-Aldrich
L-Glutamic acid hydrochloride
Glutamic acid, European Pharmacopoeia (EP) Reference Standard
Sigma-Aldrich
L-Glutamic acid, BioUltra, ≥99.5% (NT)
Sigma-Aldrich
L-Glutamic acid, ReagentPlus®, ≥99% (HPLC)
Sigma-Aldrich
L-Glutamic acid, FCC
Sigma-Aldrich
Ivermectin
Sigma-Aldrich
D-Glutamic acid, ≥99% (TLC)
Sigma-Aldrich
L-Glutamic acid, from non-animal source, meets EP testing specifications, suitable for cell culture, 98.5-100.5%
Supelco
L-Glutamic acid, Pharmaceutical Secondary Standard; Certified Reference Material
Supelco
L-Glutamic acid, certified reference material, TraceCERT®, Manufactured by: Sigma-Aldrich Production GmbH, Switzerland
Ivermectin, European Pharmacopoeia (EP) Reference Standard